theMednet - When would you consider using a BTK inhibitor in the frontline setting for lymphoplasmacytic lymphoma (LPL) or Waldenstrom's Macroglobulinemia?

Topics: Hematologic Malignancies • Medical Oncology • Lymphoma • Hematology

When would you consider using a BTK inhibitor in the frontline setting for lymphoplasmacytic lymphoma (LPL) or Waldenstrom's Macroglobulinemia?

Does your answer differ for younger vs older patients?